Financhill
Back

AbCellera Biologics Vs. InMed Pharmaceuticals Industry Stock Comparison

Sell
35

ABCL
AbCellera Biologics

Last Price:
3.76
Seasonality Move:
-3.7%
Sell
11

INM
InMed Pharmaceuticals

Last Price:
0.23
Seasonality Move:
-31.59%
Sell
35
AbCellera Biologics (ABCL) is a Sell

Is AbCellera Biologics a Buy, Sell or Hold?

  • The current AbCellera Biologics [ABCL] share price is $3.76. The Score for ABCL is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ABCL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
11
InMed Pharmaceuticals (INM) is a Sell

Is InMed Pharmaceuticals a Buy, Sell or Hold?

  • The current InMed Pharmaceuticals [INM] share price is $0.23. The Score for INM is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
  • INM is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ABCL Stock Price Chart

What is AbCellera Biologics's stock price today?

  • The AbCellera Biologics share price today is $3.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABCL is experiencing slight buying pressure.

INM Stock Price Chart

What is InMed Pharmaceuticals's stock price today?

  • The InMed Pharmaceuticals share price today is $0.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INM is experiencing selling pressure, which indicates risk of future bearish movement.

ABCL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 34.23 Sell
Chaikin Money Flow: 682276 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.95 - 4.53) Sell
Bollinger Bands (100): (4.41 - 5.49) Sell

INM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 29.26 Sell
Chaikin Money Flow: -367190 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.28 - 0.36) Sell
Bollinger Bands (100): (0.32 - 0.4) Sell

ABCL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.88 Sell
20-day SMA: 4.18 Sell
50-day SMA: 4.58 Sell
200-day SMA: 5.12 Sell
8-day EMA: 3.89 Sell
20-day EMA: 4.13 Sell
50-day EMA: 4.47 Sell
200-day EMA: 5.37 Sell

INM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.28 Sell
20-day SMA: 0.32 Sell
50-day SMA: 0.35 Sell
200-day SMA: 0.55 Sell
8-day EMA: 0.28 Sell
20-day EMA: 0.31 Sell
50-day EMA: 0.34 Sell
200-day EMA: 0.97 Sell

AbCellera Biologics Earnings Growth & ABCL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.05 per share.

InMed Pharmaceuticals Earnings Growth & INM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

AbCellera Biologics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

InMed Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):